FLOT1 and head and neck squamous cell carcinoma: (OS: 46.0% vs. 75.2% at 5 years, P = 0.00025; RFS: 43.0% vs. 79.4% at 5 years, respectively) Thus, FLOT1 may be relevant for the prognosis of HNSCC patients receiving RT.